A meta-analysis of five studies (10,833 patients) found that GLP-1 receptor agonist users were twice as likely to have inadequate…
Browsing: Clinical Updates
A nationwide study from Japan found that the risk of colorectal cancer (CRC) varies among subgroups of steatotic liver disease…
Despite guidelines recommending screening for esophageal adenocarcinoma (OAC) and its precursor, Barrett’s esophagus (BO), uptake remains low due to the…
As the 100th anniversary of Crohn’s disease approaches, the field of inflammatory bowel disease (IBD) has seen remarkable advancements, including…
A randomized controlled trial comparing a digitally delivered gut-directed hypnotherapy (GDH) program (Nerva) to an active control found that GDH…
As we approach the 100th anniversary of Crohn’s disease first being described, Clinical Gastroenterology and Hepatology (CGH) is diving into the past, present,…
Vijay Yajnik, VP, Head of Gastroenterology TA, US Medical Affairs, highlights the clinical progress in eosinophilic esophagitis (EoE), emphasizing the…
Biomerica’s inFoods® IBS blood test is transforming Irritable Bowel Syndrome (IBS) management by identifying personalized dietary triggers, significantly reducing abdominal…
A proposed rule could dramatically expand Medicare and Medicaid coverage for GLP-1 receptor agonists like Wegovy and Zepbound, making these…
The definition and significance of tumor deposits (TDs) have evolved over the years. An estimated 20% of patients with colon…